mAbxience
Pre-clinicalDevelops and manufactures biosimilar monoclonal antibodies for various therapeutic areas.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
Develops and manufactures biosimilar monoclonal antibodies for various therapeutic areas.
AntibodiesBiologicsBiosimilars
Funding History
1UndisclosedUndisclosedJun 15, 2019